Literature DB >> 17262891

The design and evaluation of placebo material for crude herbals: Artemisia afra herb as a model.

A Dube1, L N Manthata, J A Syce.   

Abstract

Herbal materials are known to present significant challenges with regard to designing credible placebos. This study intended to demonstrate the possibility of designing placebo material for crude herbals and used Artemisia afra, a popular traditional herbal medicine in South Africa, as a model. To produce the placebo, step-wise solvent extractions were conducted on the plant leaves and the process was monitored spectrophotometrically and using high performance liquid chromatography (HPLC) with diode array detection. The odour and taste between the placebo and A. afra was matched by inclusion of linalool and sodium saccharin, respectively. The muscle relaxant activity of the placebo was evaluated using an isolated guinea-pig tracheal muscle preparation. The UV absorbance of the extracts and the HPLC chromatograms, showed that most of the phytochemical constituents had been removed and the placebo closely resembled the A. afra leaves. The EC(50) of the placebo and the leaves were 4846.00 and 68.49 mg/mL, respectively, which showed that not only did the A. afra leaves possess muscle relaxant activity, but that the placebo did not possess any significant activity compared with the A. afra leaves (p value 0.0001). These results demonstrated that it is possible to design credible, pharmacologically inert placebo material for crude herbals. Copyright 2007 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17262891     DOI: 10.1002/ptr.2084

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  5 in total

1.  Unique aspects of herbal whole system research.

Authors:  Suzanna M Zick; Herbert Schwabl; Andrew Flower; Bibhas Chakraborty; Kristine Hirschkorn
Journal:  Explore (NY)       Date:  2009 Mar-Apr       Impact factor: 1.775

2.  WHO Trial Registration Data Set (TRDS) extension for traditional Chinese medicine 2020: recommendations, explanation, and elaboration.

Authors:  Xuan Zhang; Liang Lan; Jacky C P Chan; Linda L D Zhong; Chung-Wah Cheng; Wai-Ching Lam; Ran Tian; Chen Zhao; Tai-Xiang Wu; Hong-Cai Shang; Ai-Ping Lyu; Zhao-Xiang Bian
Journal:  BMC Med Res Methodol       Date:  2020-07-17       Impact factor: 4.615

3.  Placebo design in WHO-registered trials of Chinese herbal medicine need improvements.

Authors:  Xuan Zhang; Ran Tian; Chen Zhao; Xudong Tang; Aiping Lu; Zhaoxiang Bian
Journal:  BMC Complement Altern Med       Date:  2019-11-06       Impact factor: 3.659

Review 4.  Effectiveness of polyherbal formulations for the treatment of type 2 Diabetes mellitus - A systematic review and meta-analysis.

Authors:  Renuka Suvarna; Revathi P Shenoy; Basavaraj S Hadapad; Anupama V Nayak
Journal:  J Ayurveda Integr Med       Date:  2021-02-05

5.  Assessing the efficacy and safety of Juan Bi Tang for dialysis-related myofascial pain in the fistula arm: Study protocol for a randomized cross-over trial.

Authors:  Yung-Tang Hsu; Hwee-Yeong Ng; Yung-Hsiang Chen; Yu-Chuen Huang; Yan-Yuh Lee; Ming-Yen Tsai
Journal:  Front Public Health       Date:  2022-08-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.